» Articles » PMID: 37550596

Asparagine Restriction Enhances CD8 T Cell Metabolic Fitness and Antitumoral Functionality Through an NRF2-dependent Stress Response

Abstract

Robust and effective T cell immune surveillance and cancer immunotherapy require proper allocation of metabolic resources to sustain energetically costly processes, including growth and cytokine production. Here, we show that asparagine (Asn) restriction on CD8 T cells exerted opposing effects during activation (early phase) and differentiation (late phase) following T cell activation. Asn restriction suppressed activation and cell cycle entry in the early phase while rapidly engaging the nuclear factor erythroid 2-related factor 2 (NRF2)-dependent stress response, conferring robust proliferation and effector function on CD8 T cells during differentiation. Mechanistically, NRF2 activation in CD8 T cells conferred by Asn restriction rewired the metabolic program by reducing the overall glucose and glutamine consumption but increasing intracellular nucleotides to promote proliferation. Accordingly, Asn restriction or NRF2 activation potentiated the T cell-mediated antitumoral response in preclinical animal models, suggesting that Asn restriction is a promising and clinically relevant strategy to enhance cancer immunotherapy. Our study revealed Asn as a critical metabolic node in directing the stress signaling to shape T cell metabolic fitness and effector functions.

Citing Articles

Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations.

Chang H, Tsai C, Hsu C, Tai T, Cheng M, Chuang Y Nat Metab. 2025; .

PMID: 40045118 DOI: 10.1038/s42255-025-01245-6.


ASPiring metabolic-immunotherapy by ASParaginase.

Shah R, Wang R Nat Metab. 2025; .

PMID: 40045117 DOI: 10.1038/s42255-025-01241-w.


HDAC3: A Multifaceted Modulator in Immunotherapy Sensitization.

Han R, Luo Y, Gao J, Zhou H, Wang Y, Chen J Vaccines (Basel). 2025; 13(2).

PMID: 40006729 PMC: 11860249. DOI: 10.3390/vaccines13020182.


Transmembrane Amino Acid Transporters in Shaping the Metabolic Profile of Breast Cancer Cell Lines: The Focus on Molecular Biological Subtype.

Dyachenko E, Belskaya L Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852119 PMC: 11763447. DOI: 10.3390/cimb47010004.


Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy.

Huang K, Han Y, Chen Y, Shen H, Zeng S, Cai C Mol Cancer. 2025; 24(1):7.

PMID: 39789606 PMC: 11716519. DOI: 10.1186/s12943-024-02205-6.


References
1.
Wang R, Green D . Metabolic checkpoints in activated T cells. Nat Immunol. 2012; 13(10):907-15. DOI: 10.1038/ni.2386. View

2.
Gerriets V, Rathmell J . Metabolic pathways in T cell fate and function. Trends Immunol. 2012; 33(4):168-73. PMC: 3319512. DOI: 10.1016/j.it.2012.01.010. View

3.
Pearce E, Pearce E . Metabolic pathways in immune cell activation and quiescence. Immunity. 2013; 38(4):633-43. PMC: 3654249. DOI: 10.1016/j.immuni.2013.04.005. View

4.
Chapman N, Boothby M, Chi H . Metabolic coordination of T cell quiescence and activation. Nat Rev Immunol. 2019; 20(1):55-70. DOI: 10.1038/s41577-019-0203-y. View

5.
Wang W, Zou W . Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy. Mol Cell. 2020; 80(3):384-395. PMC: 7655528. DOI: 10.1016/j.molcel.2020.09.006. View